XML 64 R53.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events (Details) - Subsequent Event - Collaborative Arrangement
$ in Millions
Oct. 28, 2020
USD ($)
numberOfDays
Segment
Subsequent Event [Line Items]  
Upfront payment receivable $ 50.0
Collaborative agreement, period after agreement execution to receive upfront payment | Segment 30
Contingent payments receivable upon achievement of development and regulatory milestones (up to) $ 39.0
Contingent payments receivable upon achievement of commercial milestones (up to) $ 60.0
Royalty percentage (in excess of) 25.00%
Company's share of clinical trial costs, percentage 50.00%
Collaborative agreement expiration, period after first commercial sale of product 12 years
Collaborative agreement, termination by counterparty, effective after written notice period | numberOfDays 180
Repayment of upfront payment upon termination, percentage 85.00%
Reimbursement of development expenses upon termination, percentage 50.00%